Pharmaceutical

Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona

New Arizona site represents Nutrishare's third pharmacy to support its ability to serve home TPN patients in all 50 states…

4 months ago

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business UpdatesEntered into a definitive…

4 months ago

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial…

4 months ago

Cingulate Provides Management Team Update

Jennifer Callahan, Chief Financial Officer, appointed Interim CEO Board member, Jay Roberts appointed Executive Chairman KANSAS CITY, Kan., Aug. 15,…

4 months ago

The Untold Truth About President Trump’s Marijuana Rescheduling

The untold truth? Rescheduling may not save the cannabis industry-it could divide it.Past IRS 280E tax liabilities won't vanish-some companies…

4 months ago

Encision Reports First Quarter Fiscal Year 2026 Results

BOULDER, CO / ACCESS Newswire / August 15, 2025 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented…

4 months ago

Hemogenyx Pharmaceuticals PLC – Third Patient Treated with HG-CT-1 CAR-T Therapy

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Third Patient Treated with HG-CT-1 CAR-T Therapy and Completion of First Adult Dose Cohort…

4 months ago

CleanSpace Continues Rapid Growth, Strengthening its Concept-to-Commercialization Model

DOYLESTOWN, Pa., Aug. 14, 2025 /PRNewswire/ -- Continuing its rapid growth, CleanSpace has significantly enhanced its leadership team, expanded its…

4 months ago

Investors Signal New Era of Deal Discipline in Healthcare IT: Post-Boom Challenges and Untapped Opportunities Emerge in H2 2025

Black Book Research Flash Survey of 110 VCs, PE partners, and M&A pros exposes shifting priorities from valuation fatigue to…

4 months ago

SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology

Marketing approval allows imminent commercialization of the Colovac device in key EU markets PARIS, FRANCE AND TAMPA, FL / ACCESS…

4 months ago